Plasma 18-hydroxycorticosterone (18-OHB) and aldosterone responses to angiotensin II (AH) and ACTH were examined in 2 patients with a 18-OHB-producing tumor (18-OHBPT) versus those in 8 patients with a aldosterone-producing adenoma (APA), 7 patients with low renin essential hypertension (LREH) and 10 normal subjects. Plasma 18-OHBand aldosterone levels and the 18-OHB:aldosterone ratio were high in patients with an APAand normal in patients with LREH.In patients with a 18-OHBPT,plasma 18-OHBand aldosterone levels were high and normal, respectively, resulting in a 2-fold greater 18-OHB:aldosterone ratio than that in patients with an APA. Patients with an APAhad a blunted response of plasma 18-OHBand aldosterone to AHand a supranormal response of these corticoids to ACTH. Patients with LREHhad a supranormal response of plasma 18-OHBand aldosterone to AHand a normal response of these corticoids to ACTH. In patients with a 18-OHBPTthe responses of both plasma 18-OHBand aldosterone to AHand ACTHclosely resembled those in patients with an APAbut not in patients with LREH.
8-Hydroxycorticosterone
(1 8-OHB) is thought to be a possible immediate precursor steroid of aldosterone in the adrenal zona glomerulosa (1) . In recent years, Vecsei et al. (2) and Kigoshi et al. (3) have reported three cases of 18-OHB-producing tumors (18-OHBPTs) which are adenomas indistinguishable morphologically from aldosteroneproducing adenomas (APAs). These patients had clinical findings suggestive of low renin essential hypertension (LREH): hypertension, normokalemia, suppressed plasma renin activity, and normal plasma or urinary aldosterone level. Howeverthey had an adrenal mass on the CTscan and a high level of plasma or urinary 1 8-OHB. In addition, our patient had a blunted response of both plasma 18-OHBand aldosterone to angiotensin II (All) and a supranormal response of these corticoids to ACTH(3). It is likely that the responses of plasma 18-OHBand aldosterone to All and ACTHin patients with a 1 8-OHBPTresemble those in patients with an APA (primary aldosteronism) (4, 5) but not in patients with essential hypertension (4). Recently we experienced an additional patient with a 18-OHBPT. To verify this possibility we compared the effects of All and ACTHin plasma 18-OHB and aldosterone in two patients with a 18-OHBPTto their 
MATERIALS AND METHODS

Subjects
Two patients with a 18-OHBPT, 8 patients with an APA, 7 patients with LREHand 10 normal subjects were studied. Clinical data of these patients and normal subjects are shown in Table 1. The two   patients with a 18-OHBPT were a 46-year-old womanpreviously described (patient 1) (3) and a 37-year-old man (patient 2), both of whomhad hypertension, normokalemia, low plasma renin activity, normal plasma aldosterone and high plasma 18-OHB levels, and a left adrenal mass on the CT scan. The diagnosis of 18-OHBPTwas confirmed by surgery in patient 1 and by a difference in the adrenal vein plasma 18-OHB levels (5,600 ng/dl in the left side and 125 ng/dl in the right side) in patient 2. The high blood pressure remains normal after surgery in patient 1 and with oral administration of the Ca antagonist nifedipine in patient 2. The patients with LREH, after the exclusion of secondary hypertension, was defined as having low plasma renin activity by both the basal and stimulated (80 mg of oral furosemide plus 4 h of ambulation) plasma renin activity levels of less than the normal range as previously described (6). The patients with LREHhad normal plasma aldosterone and 18-OHBlevels. The patients with an APAhad hypertension, hypokalemia, low plasma renin activity, high plasma aldosterone and 18-OHB levels, and a unilateral adrenal mass on the CT scan. The diagnosis of APAwas confirmed by surgery in all the patients with an APA. The normal subjects were in good health for their age and no history of hypertension, heart disease or renal disease. None of the subjects studied was taking drugs at the time of study. All the patients and the normal subjects were maintained a 170-200 meq sodium intake daily until otherwise indicated. Meth ods Graded All infusions Graded All infusions were started between 0800 h and 0900 h with subjects supine. The subjects were maintained a 25 meq sodium intake for 4 days before the All infusions. All amide (Hypertensin;
Ciba-Geigy, Basel, Switzerland) was infused iv at rates of 2, 4 and 8 ng/kg/min for 30 min each. Blood pressure with subjects supine was determined with a cuff sphygmomanometer at 2-to 5-min in- Data in the patients with an APAand LREH, and the normal subjects are expressed as the mean ± SEM.For comparison between the patients with an APAor LREHand normal subjects, statistical analysis was made by Student' s unpaired t-test when difference between means was evaluated, or by analysis of variance with the parallel line assay (8) whenthe plasma corticoid responses to All or ACTH were compared. Mean blood pressure was higher in both patients with an APAand LREHthan in normal subjects Responsiveness in 1 8-OHB-Producing Tumors (p <0.01). Plasma 18-OHB and aldosterone levels and the plasma 18-OHB aldosterone ratio were higher in patients with an APA (p<0.05 or less) than in normal subjects and normal in patients with LREH. In patients with a 18-OHBPT, mean blood pressure and plasma 18-OHB level were high whereas plasma aldosterone level was normal. The plasma 18-OHB: aldosterone ratio in these patients was about 2-fold that in patients with an APA. Graded All infusions caused dose-related increases in mean blood pressure in the patients with an APA (p<0.01), LREH (p<0.01) and a 18-OHBPT, and the normal subjects (p<0.01). The mean blood pressure response to the All infusions, however, was greater in the patients with an APA(p<0.01), LREH(p<0.01) and a 18-OHBPT than in the normal subjects. Plasma 1 8-OHBand aldosterone levels during the All infusions increased in a dosedependent manner in the patients with LREHand the normal subjects (p <0.01), but did not increase in the patients with an APAand a 18-OHBPT.The responses of these corticoids to the All infusions were greater in the patients with LREHthan in the normal subjects (p <0.01). The plasma 18-OHB: aldosterone ratio during the All infusions remained unchanged in all the four groups. ACTH injection (Table 3 , Fig. 2 ) Plasma cortisol level was similar in the patients with an APA, LREHand a 18-OHBPT, and the normal subjects. Plasma 18-OHB and aldosterone levels and the plasma 18-OHB: aldosterone ratio were higher in the patients with an APA (p<0.05 or less) than in the normal subjects and normal in the patients with LREH.In the patients with a 1 8-OHBPT, plasma 18-OHB level was high, whereas plasma aldosterone level was normal. Thus, the plasma 18-OHB: aldosterone ratio was about 2-fold that in the patients with an APA. ACTHinjection resulted in similar increases in plasma cortisol 30 and 60 min later in the four groups (p<0.01). ACTH injection also produced increases in plasma 1 8-OHB and aldosterone 30 and 60 min later in all the four groups (p < 0.01). The responses of these corticoids to the ACTHinjection, however, were greater in both the patients with an APA(p<0.01) and a 18-OHBPTthan in the normal subjects and normal in the patients with LREH.The plasma 18-OHB: aldosterone ratio tended to increase during the ACTHinjection in the four groups.
RESULTS
Graded All infusions (
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DISCUSSION
Marked elevation of plasma 18-OHBtogether with high plasma aldosterone is a characteristic finding in patients with an APA, but not in patients with adrenal hyperplasia (9, 10). The plasma 18-OHB : aldosterone ratio, a marker of type II corticosterone methyl oxidase (CMOII) activity (1 1), in patients with an APA(9) and those with adrenal hyperplasia (9, 10) is slightly high compared to control subjects, probably reflecting an inhibiting effect of hypokalemia on the final step of aldosterone biosynthesis at the CMOII level (9). In patients with essential hypertension plasma 18-OHB and aldosterone levels have been reported to be within normal ranges with a normal plasma 18-OHB: aldosterone ratio (4, 10). In agreement with these findings, plasma 1 8-OHBand aldosterone levels and the plasma 18-OHB: aldosterone ratio in the present study were high in patients with an APAand normal in patients with LREH. However, two patients with a 18-OHBPT had high plasma 18-OHB and normal plasma aldosterone levels, showing a 2-fold greater plasma 18-OHB : aldosterone ratio than that in patients with an APA. Since serum potassium in our patients with a 18-OHBPT was normal, high plasma 18-OHB: aldosterone ratio in these patients cannot be explained by a modulating effect of potassium on the enzymatic conversion of 18-OHB to aldosterone. Unknown factor(s) other than potassium appears to be responsible for the impaired conversion of 18-OHBto aldosterone in our patients with a 18-OHBPT.
The mechanism responsible for the low renin hypertension observed in two patients with a 18-OHBPTis obscure because 18-OHB has little or no mineralocorticoid activity (1 , 12) . Our patients with a 18-OHBPThad a normal aldosterone production relative to suppressed plasma renin activity, suggesting a state of inappropriately high aldosterone production. It has been suggested that aldosterone production from aldosteronomas, even if its level is lower than in classic primary aldosteronism, maybe relatively autonomousand this may cause low renin hypertension with normokalemia in the early phase of this disorder (13). Although data in patients with normokalemic primary aldosteronism are not available in the present study, such an inappropriately high aldosterone production from 18-OHB-producing adenomas might be responsible for the pathogenesis in our patients with a 18-OHBPT. In the present study, patients with an APAhad a blunted response of both plasma 18-OHB and aldosterone to All and a supranormal response of these corticoids to ACTH.In contrast, patients with LREHhad a supranormal response of both plasma 18-OHBand aldosterone to All and a normal response of these corticoids to ACTH. and Guthrie (5). In two patients with a 18-OHBPT, however, the pattern of the responses of plasma 18-OHB and aldosterone to All and ACTHclosely resembled that in patients with an APAand was different from that in patients with LREH.This implicates that our two patients with a 18-OHBPT, showing high plasma 18-OHBand normal plasma aldosterone levels, have a property similar to APAs in the responses of these corticoids to All and ACTH. This similarity of the corticoid responses to All and ACTHbetween 18-OHBs and APAs, despite the presence of an abnormally high plasma 1 8-OHB: aldosterone ratio in 18-OHBPTs, suggests that 18-OHBPTmay be a variant form of APAs, producing a large amount of 18-OHBand a small amountof aldosterone. The precise mechanism of the altered corticoid responses to All and ACTHin patients with a 18-OHBPTis not clear from the present study. A blunted response of plasma 1 8-OHB and aldosterone to All in patients with a 18-OHBPTas well as in those with an APAcould be attributed to a fewer number and lower affinity of All receptors present in adrenal tumor tissues than in normal adrenal tissues (14) or to the exogenous All-induced inhibition of the endogenousACTH secretion on which 18-OHBand aldosterone are abnormally dependent (4). In contrast, a supranormal response of plasma 18-OHBand aldosterone to All in patients with LREHcould be due to an increase in the number or the affinity of All receptors (4). On the other hand, a supranormal response of plasma 18-OHB and aldosterone to ACTH in patients with a 18-OHBPTas well as in those with an APAmay be due to the hyperresponsiveness of the early steps in aldosterone biosynthesis to ACTH (5) or presumably to the alteration of ACTHreceptors.
In conclusion, two patients with a 18-OHBPT, who showed high plasma 18-OHB and normal plasma aldosterone levels, had a blunted response of both plasma 18-OHBand aldosterone to All and a supranormal response of these corticoids to ACTH,closely resembling those in patients with an APA.The findings in these patients however were obviously different from those in patients with
LREHwhoshowed a supranormal response of plasma 18-OHB and aldosterone to All and a normal response of these corticoids to ACTH. Thus, measurements of plasma 18-OHBand aldosterone levels and their responses to All and ACTHmay provide a useful information in differentiating patients with a 18-OHBPTfrom not only patients with an APAbut also those with LREH.
